Advancing the frontiers of clinical drug development

CHDR is an independent institute specialising in innovative early-stage clinical drug research.

Our Story Our Unit

More

First study to be approved under the new CTR in The Netherlands submitted by CHD...

10 Aug 2022

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease.

03 Aug 2022

Interested to join our team? Browse the latest openings

Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success

A biomarker for pharmacological effects on cortical excitability

A multi-modal, standardised test battery for pain

A ‘one-stop-shop’ for all cardiology needs